ORIC Pharmaceuticals, Inc. Made Headway
Fri, Apr 01, 2022 at 05:30 PM
ORIC Pharmaceuticals, Inc. (ORIC:NASDAQ) shot up at $6.6, a gain of 23.6%. The stock appeared on our News Catalysts scanner on Mon, Mar 28, 2022 at 05:30 PM in the 'INSIDER' category. From Thu, Mar 17, 2022, the stock recorded 44.44% Up Days and 50.00% Green Days
About ORIC Pharmaceuticals, Inc. (ORIC:NASDAQ)
ORIC Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. It has a pipeline of therapies designed to counter resistance mechanisms in cancer by leveraging its expertise within three specific areas: hormone-dependent cancers, precision oncology, and key tumor dependencies. The company has product candidates namely, ORIC-101 and ORIC-533.
Top 10 Gainers:
- Takung Art Co., Ltd. (TKAT:NYSEMKT), 61.78%
- Chicken Soup for the Soul Entertainment, Inc. (CSSE:NASDAQ), 43.8%
- Manning & Napier, Inc. (MN:NYSE), 40.4%
- Hudson Capital Inc. (HUSN:NASDAQ), 36.27%
- Greenidge Generation Holdings Inc. (GREE:NASDAQ), 33.95%
- Weidai Ltd. (WEI:NYSE), 28.83%
- AeroClean Technologies Inc. (AERC:NASDAQ), 27.22%
- Clovis Oncology, Inc. (CLVS:NASDAQ), 23.76%
- ORIC Pharmaceuticals, Inc. (ORIC:NASDAQ), 23.6%
- Sanchez Midstream Partners LP (SNMP:NYSEMKT), 22.63%